Hyperphagia and early-onset, severe obesity: What does good multidisciplinary team (MDT) care look like for patients living with MC4R pathway diseases?

Friday, 19 May 2023, Dublin, Ireland

This symposium was organised and funded by Rhythm Pharmaceuticals and is intended for Healthcare Professionals only.

Please login or signup to unlock the videos.

Rhythm Pharmaceuticals is leveraging a IQVIA's Healthcare Professional Authentication solution to identify your eligibility to access this video content. If you already have an IQVIA account using it with other healthcare providers, please click 'Login' otherwise click 'Signup'.

Prof Le Roux, Prof Farooqi and Dr Forsythe raise awareness of the role of the MC4R pathway in the regulation of bodyweight, and how genetic variants within the pathway can lead to hyperphagia and early-onset, severe obesity at ECO 2023. The speakers discuss understanding monogenic and syndromic MC4R pathway diseases, how to recognise symptoms and when to refer for genetic testing, whilst highlighting the importance of MDT care when treating patients living with MC4R pathway diseases

Speakers:

Photo of Prof. Carel Le Roux

Prof Carel Le Roux

(Ireland)

Professor Sadaf Farooqi

(UK)

Dr Elizabeth Forsythe

(UK)